Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Avalon creates pure-play biotech VC with new $135M fund

After 11 funds that balanced tech and life sciences, the new Avalon BioVentures will preserve the firm’s sweat equity model

By Paul Bonanos, Associate Editor
December 6, 2022 3:29 PM UTC

Avalon Ventures is decoupling its life sciences investment operations from other tech investments to create Avalon BioVentures, a pure-play biotech firm with a new $135 million fund and an incubator in San Diego.

Managing Partner Jay Lichter told BioCentury the firm’s LPs wanted more flexibility to allocate cash to the life sciences and technology sectors as they pleased, driving the decision to raise the Avalon BioVentures I, or ABV1, fund...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Avalon Ventures